소식
회사 소개
아벨리노는 유전자 분석을 활용 가능한 의료 정보로 전환하여 모두를 위해 더욱 건강한 미래를 만듭니다. 인공지능과 머신 러닝으로 작동하는 유전적 발견 엔진은 파괴적인 의료 혁신을 선도합니다. 아벨리노의 전문 지식은 안과, 종양학, 병원체학 및 전염병 분야에서 유전학이 미치는 영향을 포함하여 광범위한 의료 전문 분야에 폭넓게 걸쳐있습니다.
인공지능 기반 알고리즘의 글로벌 리더인 아벨리노의 진단은 안과 전문의에게 안질환 예측, 질병 진행 예방, 궁극적인 시력 보존이 가능한 맞춤형 유전자 데이터를 제공합니다.
아벨리노는 2008년을 시작으로 100만 건 이상의 안질환 유전자 검사를 완료했으며 미국, 한국, 일본에서 상용화되었습니다. 캘리포니아에 위치한 세계 최고 수준의 CLIA 인증 연구소는 300만 명 이상의 환자를 대상으로 COVID 및 RSV 검사를 수행했습니다.
Avellino’s research and development team has made groundbreaking discoveries leveraging genetic data, with programs in early detection of oncology, a polygenic risk analysis for glaucoma, and a siRNA gene-silencing therapeutic for the treatment of granular corneal dystrophy type II (currently in preclinical development). With a focus on health equity, Avellino prioritizes the inclusion of ethnically diverse populations in its studies to maximize the impact of its genomics breakthroughs for global healthcare. Avellino is headquartered in Silicon Valley, California, with operations in the UK.
보도 자료
Avellino는 이사회에 합류한 Virginia Gambale을 환영합니다
Gambale의 데이터 기술 및 재무 분야 경험은 Avellino의 생물정보학 정밀 의학 사명을 지원합니다.
Avellino Enters into Distribution Agreement With Keeler to Sell AvaGen, The Genetic Eye Test
Avellino and Keeler, a global ophthalmic device manufacturer and distributor, have entered into an agreement where Keeler will distribute AvaGen on its US website. AvaGen
Avellino, 코로나19, 호흡기세포융합바이러스 (RSV), 인플루엔자 A 및 B를 검출하는 조합 검사 출시
검사는 새로운 RSV 분석을 통해 오미크론 변종, "플루로나" 및 겨울 바이러스 감염의 전례 없는 급증을 지원한다.
헤이워드 시, Avellino Lab 코로나19 검사 리더십 2주년 기념
헤이워드 시는 어제 헤이워드 소방서가 미국 최초로 무료로 시에서 주도한 코로나 검사 센터를 출범한지 2주년이 되는 것을 기념했다.
세계적으로 인정받는 과학 정책 및 유전체학 전문가 Genya Dana 박사 Avellino에 글로벌 건강 정책 책임자로 합류
전 세계 경제 포럼 의료 책임자는 전 세계적으로 과학 및 기술 혁신을 발전시키는 유전체학, 생명 공학 및 정책 설계에 대한 깊은 지식과 전문성을 제공한다.
오미크론 급증으로 베이 지역 선두 코로나 검사 제공업체의 새로운 드라이브 스루 커뮤니티 코로나 검사기관 개설 촉진
목적/이유: Avellino는 캘리포니아주 최대 코로나 검사 제공업체 중 하나로서 캘리포니아주 멘로 파크에 있는 회사 본사에 새로운 드라이브 스루 코로나19 검사기관을 개설하여 홈 테스트 부족과 다른 곳의 긴 검사 대기시간으로 인한 더 많은 검사 제공이 시급한 상황을 지원하고 있다.
Nationally Recognized Ophthalmologist Dr. Elizabeth Yeu Joins Avellino’s Board of Directors
Dr. Yeu’s depth of experience will help Avellino as the company continues to provide genetic-based diagnostics for the ophthalmic industry and expands its innovative product
Avellino Appoints Jon Robson as CEO and Member of the Board of Directors
Avellino Lab USA, Inc. (Avellino) is pleased to announce Jon Robson as the company’s new CEO and member of the Board of Directors. Jon will
Avellino Partners with Sugentech, Inc. to Distribute SGTi-flex COVID-19 IgG Antibody Test
Avellino and Sugentech, Inc., a bio- and nano- based technology and in-vitro diagnostic firm based in Korea, as part of their partnership agreement announced in
Avellino Surpasses Two Million COVID-19 Tests in the United States
Avellino today announced that more than two million of its SARS-CoV-2/COVID-19 Tests (AvellinoCoV2) have now been performed in the United States. Avellino was one of
Avellino Launches AvaGenTM Nationwide as the First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophies
Avellino today announced full nationwide availability in the U.S. of AvaGen™, The Genetic Eye Test, as the first genetic test that helps determine a patient’s
Laiq Ahmad Joins Avellino Labs as Chief Technology Officer
Ahmad brings more than 22 years of experience to the role, with advanced knowledge of digital transformation, cloud technologies, big data, AI, and machine learning.
Former World Economic Forum Member of the Managing Board Murat Sönmez Joins Avellino’s Board of Directors
Avellino Lab USA, Inc. (Avellino) today announced the appointment of Murat Sönmez to the company’s Board of Directors. Murat is a former World Economic Forum
Avellino Donates $25,000 to National Keratoconus Foundation to Support World Keratoconus Day and Disease Education
Avellino Lab USA, Inc. (Avellino), in honor of World Keratoconus Day, today announced a $25,000 donation to the National Keratoconus Foundation (NKCF) to support their
Avellino Expands its Board of Directors and Welcomes New Executive Management Members
Avellino announced today the appointment of three new members to its Board of Directors.
Avellino Introduces New Multiplex Respiratory Panel
Avellino announced today that the company has developed a novel multi-panel RT-PCR-based virus assay, AvellinoCoV2-Respiratory, which has been validated following the U.S. Food and Drug
Avellino and Sugentech Announce Strategic Collaboration
Partnership Focused In Short Term On COVID-19 Genetic Diagnostics and Solutions, Long Term Collaboration On Partner Diagnostics and Therapeutics
Bay Area Lab Aims to Distribute Millions of Coronavirus Test After Creating Their Own
The NBC Bay Area Investigative Unit was granted exclusive access inside Avellino Laboratory, a Menlo Park-based genetic research firm that designed its own test for
Avellino’s Coronavirus test now available, FDA approval pending
Avellino Lab USA Inc. has developed a diagnostic test for the novel coronavirus SARS-CoV-2, which has been validated in keeping with the U.S. Food and
Avellino Labs Receives CLIA Certification For AvaGen
Avellino Labs is proud to announce that it has received CLIA certification for AvaGen, a genetic diagnostic test for keratoconus and corneal dystrophies. With the
Prominent Technologist William (Bill) F. Stasior Joins Avellino Labs Executive Advisory Committee
Avellino Labs announced the addition of William F. Stasior to the company’s Executive Advisory Committee and consultant to the company. Mr Stasior will advance Avellino
Eric Bernabei Joins Avellino Labs as Chief Sales and Marketing Officer
Avellino Labs, global biotechnology and genetic science innovators, announced Eric Bernabei as the company’s chief sales and marketing officer (CSMO). The addition of Bernabei will
